CCCR News and Updates
1 - 10 of 50
Children’s Hospital of Philadelphia Receives $650,000 Donation to Advance Brain Tumor Research and Discoveries Within the Children’s Brain Tumor Network
Published on in CHOP News
The Lilabean Foundation’s support will accelerate pace of translational research, discovery of new treatments for children and young adults with brain tumors.
CHOP Researchers Define a 3-Tiered Molecular Classification of Pediatric Differentiated Thyroid Cancer, where Fusion Oncogenes Predict the Most Invasive Behavior
Published on in CHOP News
CHOP researchers have defined a 3-tiered molecular classification of pediatric differentiated thyroid cancer, where fusion oncogenes predict the most invasive behavior.
Five Proposals Receive Seed Funds to Develop Medical Devices for Children
Published on in CHOP News
Pennsylvania Pediatric Medical Device Consortium supports projects addressing infant feeding development, neonatal jaundice, pediatric dysphagia, unplanned extubations, and adrenal crisis
Small Study Shows Convalescent Plasma is Safe to Use in Pediatric Patients with COVID-19
Published on in CHOP News
CHOP researchers show convalescent plasma appears to be a safe and possibly effective treatment for children with life-threatening cases of COVID-19.
New Treatment Shows Success in High-Risk Solid Tumors
Published on in CHOP News
The CHOP-engineered therapy overcomes common drug resistance and has potential to elicit fewer toxicities than most cancer treatments.
CHOP Researchers Uncover Mechanism that Helps Adenovirus Replicate Efficiently in Host Cells
Published on in CHOP News
In a study published in Nature Microbiology, CHOP researchers uncover a ubiquitination mechanism that helps adenovirus replicate efficiently in host cells.
Children’s Hospital of Philadelphia Announces Endowed Chair in Pediatric Neuroblastoma Research
Published on in CHOP News
CHOP recipient, physician-scientist Dr. Yael Mossé, is innovating targeted, less toxic therapies for cancer affecting mostly infants and young children.
A Cancer-causing Gene May Benefit Patients During Chemotherapy
Published on in CHOP News, Cancer Connections
CHOP researchers report that a well-known gene that normally drives cancer could potentially benefit cancer patients if used in combination with chemotherapy.
Single Cell Technology Zooms In for Clearer View of High-risk Pediatric Cancers
Published on in CHOP News
CHOP researchers were awarded a five-year research grant totaling $12.5 million to create the Center for Pediatric Tumor Cell Atlas as part of a 10-centernational consortium.
CHOP’s Breakthrough Cancer Immunotherapy Program Receives Generous Grant from the Emily Whitehead Foundation
Published on in CHOP News, Cancer Connections
Emily Whitehead, the first pediatric patient to receive CAR T-cell therapy, and her family honor the CHOP team who saved her life with a $250,000 research grant to expand the use of the therapy for relapsed or refractory ALL.